CERAVIX Neatly packaged poison

See: Gardasil

Articles
Ceravix deaths
UK Association of HPV Vaccine Injured Daughters (AHVID)

Ceravix contents

Ashleigh Cave

Justin Healy
Dr. Diane Harper
Dr. Harald zur Hausen

[vid] CERVARIX VACCINE GSK'S PROMOTIONAL FLAWS

[2015 Sept] Did HPV cervical cancer vaccine cause life-changing illnesses in Kent teenagers?

[2015 May] Thousands of teenage girls enduring debilitating illnesses after routine school cancer vaccination

[2015 Jan] What if HPV does NOT cause cervical cancer? By Norma Erickson and Peter H. Duesberg, PhD  If HPV vaccines are useless, it is certainly not worth submitting yourself (or your loved ones) to the 2.3 to 2.5% risk of serious adverse reactions AND the 2.4 to 3.3% risk of developing a new medical condition potentially indicative of autoimmune disorders experienced by Merck’s Gardasil 9 clinical trial participantsALL RISK AND NO BENEFIT IS NOT A WISE MEDICAL CHOICE UNDER ANY CIRCUMSTANCES.

Quotes
"Medical literature for aluminum hydroxide and for ASO4 suggests that a subgroup of injectees will be inclined towards arthritic processes and neurodegeneration. Cervarix seems like a way to augment sales of methotrexate and related pharmeceuticals."--Teresa CERVARIX also contains


Video
 
Gardasil and Cervarix - Merck's murder weapons.  For information on my daughter, google Brooke Petkevicius the Thank You Fairy
http://www.thankyoufairy.blogspot.com

Quotes
So what exactly is this new high potency adjuvant?  We're told by the press release that MPL (AS04),  is a "derivative of the lipid A molecule found in Gram-negative bacteria, is extracted from bacterial cell walls and is one of the most potent regulators of the immune response, used by the body to alert itself to bacterial infections."  Full name of the lipid is monophosphoryl lipid A (MPL)
    This news should put everyone on high alert because guess what?  Lipids are oils/fatty acids and according to Matsumoto, MPL is identified in declassified documents as one of two squalene emulsions used in the Army's new "recombinant protective antigen anthrax vaccine (rPA)  which the FDA, the National Institutes of Health (NIH) and the Department of Defense fast-tracked into clinical trials in1998. The other squalene adjuvant they used was Chiron's MF59. [2005] A Glimpse into the Scary World of Vaccine Adjuvants By Edda West